JTI to Launch "Mevius Gold Purple Mint" Pod in 2024

JTI by 2FIRSTS.ai
Dec.25.2023
JTI to Launch "Mevius Gold Purple Mint" Pod in 2024
Japanese tobacco company, Japan Tobacco, will gradually introduce a new tobacco device "With 2" with a "Mevius Gold Purple Mint" pod from January 22, 2024.

Japanese media Mynavi reported on December 25th that Japan Tobacco will gradually launch the companion pod "Mevius Gold Purple Mint" in its tobacco device "With 2" starting from January 22nd, 2024. This product includes five pods and one tobacco box, with a price of 580 yen (about 29 yuan) and will be sold in convenience stores, tobacco shops, and other locations nationwide.

 

With 2" utilizes cutting-edge plant decarbonization technology, using oil smoke to generate smoke through capsules filled with tobacco particles, achieving the functionalities of "zero pre-heating time," "almost imperceptible tobacco flavor," and "flavor without any unwelcome taste.

 

Currently, the sales of flavored tobacco are seeing a significant increase in the domestic tobacco market in Japan. Among them, both traditional cigarettes and heated tobacco options, the berry flavor is the top choice in terms of market share. As a result, in response to market demand, "With 2" has also launched a "berry flavor" option.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
Philip Morris Japan Launches New TEREA “Stellar Pearl,” Featuring Mint and Yellow Citrus Notes
Philip Morris Japan Launches New TEREA “Stellar Pearl,” Featuring Mint and Yellow Citrus Notes
Philip Morris Japan announced the launch of a new TEREA heated tobacco stick for the IQOS ILUMA series, “TEREA Stellar Pearl,” featuring a crushable capsule mint profile. The product will go on sale in Japan through offline retail channels from Jan. 19 and will be rolled out on the company’s official e-commerce store from Jan. 29, priced at 580 yen (about $3.6) per pack.
Jan.14 by 2FIRSTS.ai
Aurora advances retail tobacco licensing ordinance to curb under-21 access to vapes and tobacco
Aurora advances retail tobacco licensing ordinance to curb under-21 access to vapes and tobacco
The Denver Post reported that Aurora’s City Council unanimously approved a retail tobacco licensure ordinance on first reading Monday night to reduce underage access to tobacco products, including e-cigarettes and vaping cartridges. The ordinance would stiffen fines for businesses that sell to people under 21 and tighten rules on where tobacco retailers can locate in the city.
Feb.26 by 2FIRSTS.ai
South Korean Court Strikes Down Health Levy on Vape Nicotine Liquids, Citing Disproportionate Penalties
South Korean Court Strikes Down Health Levy on Vape Nicotine Liquids, Citing Disproportionate Penalties
A Seoul court has annulled South Korea’s health-levy assessments imposed on multiple importers of nicotine liquids used for vaping. While the court agreed the nicotine could be treated as “tobacco” because it was found to be leaf-derived, it ruled the levy—stacked with other taxes and calculated on a blunt, volume-only basis—was so severe it effectively deprived businesses of the ability to operate, breaching constitutional proportionality and equality standards.
Jan.26 by 2FIRSTS.ai
Reuters/AP: China Cancels E-cigarette Export Tax Rebate, Manufacturing Industry Faces Cost and Risk Pressures
Reuters/AP: China Cancels E-cigarette Export Tax Rebate, Manufacturing Industry Faces Cost and Risk Pressures
China officially cancels e-cigarette export tax rebate, putting manufacturing under cost and risk pressure.
Jan.16 by 2FIRSTS.ai
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11